Most patients do best when they take the injection on the same day each week, maintain regular meals, and stay well hydrated throughout treatment
The dual incretin advantage Tirzepatide activates two incretin receptors simultaneously: GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1)
Abdomen injections The abdomen, specifically the area at least 2 inches from the navel, is the most common injection site
Someone may have an allergy or sensitivity to one of the ingredients in Cellgevity
To help you feel confident and supported throughout your journey, weve put together simple guidance and helpful tips
Citius is encouraged by the constructive engagement with the FDA, Leonard Mazur, the companys chairman and CEO, said in a statement on Friday, adding that Citius plans to complete the remediation activities by the end of 2023 and file a resubmission early in 2024